The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
The aim of the present study was to conduct a meta-analysis of the effectiveness of tofacitinib, a novel oral Janus kinase inhibitor, recently approved for the treatment of active rheumatoid arthritis in patients who have failed previous treatment with methotrexate (MTX) or other disease-modifying a...
Main Authors: | Kawalec, Paweł, Mikrut, Alicja, Wiśniewska, Natalia, Pilc, Andrzej |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer London
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778229/ |
Similar Items
-
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
by: Kawalec, Paweł, et al.
Published: (2013) -
The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and
Meta-Analysis
by: Kawalec, Paweł, et al.
Published: (2014) -
Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
by: Ni, Han, et al.
Published: (2013) -
Nevirapine-Based Regimens in HIV-Infected Antiretroviral-Naive Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Kawalec, Paweł, et al.
Published: (2013) -
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
by: Curtis, Jeffrey R, et al.
Published: (2016)